AHRQ fact sheet aligns providers to National Quality Strategy

Laura Pedulli | | Health Exec | Economics

The Agency for Healthcare Research and Quality (AHRQ) has published a new fact sheet to align providers to the National Quality Strategy (NQS).

The fact sheet specifically outlines nine levers in the NQS to serve as a guiding force in quality improvement efforts in the U.S. for federal, state and private-sector stakeholders to improve patient health and healthcare quality.

“Stakeholders can now align to the strategy in a new way, using one or more of the nine ‘levers’... Each lever represents a core business function, resource and/or action that stakeholders can use to align to the strategy. In many cases, stakeholders may already be using these levers but haven’t connected these activities to NQS alignment,” according to the agency.

These nine levers include: payment; public reporting; learning and technical assistance; certification, accreditation and regulation; consumer incentives and benefit designs; measurement and feedback; health IT; workforce development; and innovation and diffusion.

Access the fact sheet here and learn more about general AHRQ efforts here.

 

 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.